Perbedaan Vale Indonesia Tbk. dan Brigit Biofarmaka Teknologi Tbk.: Vale Indonesia Tbk. diperdagangkan di Rp4.830 (kapitalisasi pasar 50,8 T, volume 24 jam 19,97 jt), sedangkan Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp240 (kapitalisasi pasar 166,01 M, volume 24 jam 324 rb). Perbedaan utamanya: Vale Indonesia Tbk. jauh lebih besar — sekitar 306× kapitalisasi pasar Brigit Biofarmaka Teknologi Tbk., dan Vale Indonesia Tbk. lebih aktif diperdagangkan (19,97 jt vs 324 rb). Mana yang lebih baik tergantung tujuan investasimu.
| INCO | OBAT | |
|---|---|---|
Kapitalisasi Pasar | 50,8 T | 166,01 M |
Volume | 19,97 jt | 324 rb |
Lot | 199,74 rb | 3,24 rb |
Perputaran | 94,95 M | 77,68 jt |
Harga Rata-rata | 4.753,92 | 239,75 |
Nilai Transaksi | 94,95 M | 77,68 jt |
Harga Ekuilibrium Indikatif | 4.830 | 240 |
Volume Ekuilibrium Indikatif | 9,32 rb | 1 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Vale Indonesia Tbk, formely PT International Nickel Indonesia, was established on July 25, 1968. PT. INCO produces nickel in matte, an intermediate product, from lateritic ores at its integrated mining and processing facilities near Soroako on the island of Sulawesi. The company is owned 58.7 % by Inco Limited of Canada, 20.1 % by Sumitomo Metal Mining Co., Ltd. of Japan.The Company is PMA
Selengkapnya di halaman INCO →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Selengkapnya di halaman OBAT →